The ritual of British politics around the NHS follows a familiar pattern. Crisis headlines. Emergency funding announcements. Waiting list statistics. A new plan with a new name. Then more crisis headlines.

What is missing from almost every iteration of this conversation is an honest reckoning with what the NHS was designed to do, what it is currently being asked to do, and why those two things are fundamentally incompatible without structural change that goes far beyond funding.

The Model Was Built for a Different Disease Burden

The NHS was created in 1948 to deal with acute illness in a country where infectious disease, trauma and maternal mortality were the dominant causes of death and disability. The model made sense: something goes wrong, you go to a professional, they fix it, you go home.

The disease burden of 2026 is dominated by chronic conditions — cardiovascular disease, type 2 diabetes, chronic obstructive pulmonary disease, chronic mental health conditions, musculoskeletal disorders, obesity-related illness. These conditions are not "fixed" in the acute sense. They require ongoing management, behavioural change, patient engagement and long-term relationships between patients and the health system.

The NHS system — primary care as triage, secondary care as intervention, hospital as the centre of gravity for serious illness — is not designed for this reality. GPs are excellent at acute assessment. They are overloaded, under-supported and structurally poorly equipped to provide the ongoing coaching, monitoring, adjustment and behavioural support that chronic disease management actually requires.

This is not a criticism of GPs. It is a structural observation. The job description has changed dramatically; the infrastructure, incentives and support have not.

Prevention is Not Taken Seriously

The evidence on the return on investment from prevention is not contested. NICE guidance and independent modelling consistently show that investment in smoking cessation, alcohol harm reduction, obesity prevention, cardiovascular risk management and hypertension detection returns multiples of the treatment costs they avoid — typically 3:1 to 7:1 in NHS cost terms.

Yet public health receives approximately 2–3% of total NHS funding. Prevention programmes are the first thing cut when NHS trusts face financial pressure — because the costs are immediate and the benefits flow over 10–20 years, beyond any individual budget cycle or political term.

This is a structural incentive problem. An NHS trust cannot capture the financial benefit of preventing a heart attack in 15 years. Its incentive is to manage the heart attack efficiently when it arrives. The people who bear the cost of today's prevention failure are the future patients and the taxpayers who will fund their treatment. They have no voice in today's commissioning decision.

Every NHS reorganisation of the past 30 years has promised to rebalance toward prevention. None has succeeded at scale. The next one won't either without addressing the incentive structure that makes this rational behaviour for local decision-makers even when it's irrational for the system as a whole.

The Patient Relationship Needs to Change

The paternalistic model — expert knows best, patient follows instructions — made sense when expertise was genuinely scarce and patients genuinely couldn't access the information on which medical recommendations were based. That world no longer exists.

Patients in 2026 have access to more clinical information than most GPs had available in the 1980s. They can read the trials that support their treatment recommendations. They can query AI systems that synthesise the literature. They can compare their symptoms against the full published evidence base before walking into a consultation.

The appropriate response to this is not to lament "Doctor Google" or to treat patient-sourced information as inherently illegitimate. It is to build a genuinely collaborative model where patients are treated as partners in their care — bringing their own observations, preferences and information, with clinicians providing the trained judgment and synthesis that remains genuinely valuable.

This requires giving patients real information. Not "come back if it gets worse" but a clear explanation of the probability distribution of outcomes, what warning signs matter, what they can do to influence the trajectory. It requires trusting patients to make decisions about their own bodies that may differ from clinical recommendations, and supporting those decisions rather than withholding information as a tool of compliance.

The data are clear that patients who understand their condition and treatment, who feel genuinely involved in decisions, have better outcomes — both in terms of adherence and in terms of actual health metrics. This is not a soft, patient-experience argument. It is a clinical effectiveness argument.

Digital Tools Could Transform This — If Deployed Properly

The potential of digital tools to extend effective NHS capacity is genuine. Remote monitoring for chronic conditions, AI-assisted triage for non-urgent primary care contacts, video consultation for appropriate cases, patient-facing apps for medication management and symptom tracking — these tools exist, work in deployment elsewhere, and could genuinely expand what the NHS can do within its resource constraints.

The NHS's track record of large-scale IT deployment is, however, genuinely poor. The National Programme for IT (NPfIT) is the most expensive IT failure in public sector history. Electronic patient records still cannot communicate between many NHS trusts. The NHS app has improved but still lacks the functionality available in private health systems elsewhere.

The right approach is not another national programme but a framework that enables effective deployment of tested, working tools at scale — with genuine accountability for delivery and a willingness to accept that some tools will fail and need replacing quickly. The culture that treats IT project failure as a career-ending catastrophe, rather than normal innovation risk, is part of what makes the NHS IT procurement environment pathological.

What Would Actually Help

I am not arguing that funding doesn't matter — it obviously does, and the NHS is seriously under-resourced relative to comparable health systems. But funding without structural change funds the wrong things more expensively.

What would actually help:

  • A genuine prevention investment with 20-year budget protection, ring-fenced from annual efficiency savings
  • Primary care designed for chronic disease management, not just acute assessment — which requires different staffing models, more pharmacists, physiotherapists, health coaches and community support workers
  • Patient-facing information and decision support tools that treat patients as adults
  • NHS IT procurement reform that enables fast deployment of working digital tools rather than multi-year waterfall projects
  • Incentives that allow local systems to capture the financial benefit of prevention investments

None of this is cheap or easy. Some of it requires difficult conversations about what the NHS is for and what patients owe themselves as well as what the system owes patients. But it is a more honest conversation than yet another funding announcement followed by yet another reorganisation.

Dr Nadia Okoro is a practising NHS clinician and a regular contributor to Daily Junction on health policy.